Radar Therapeutics is a biotechnology company pioneering precision-expressed, mRNA-based therapeutics. By leveraging single-cell transcriptomics and RNA-editing biology, it aims to create programmable RNAs that read a cell’s state and reprogram targeted cells in real time to minimize off-target effects. The company emphasizes designing smart mRNAs that are read in the right cells at the right time, enabling precision therapeutics and safer, scalable in vivo treatments. Based in the United States with roots in leading research institutions, Radar Therapeutics focuses on developing next-generation genetic medicines for complex diseases.
No recent news for this company.
No recent deals for this company.